BETA ADRENOCEPTOR BLOCKERS. OCH 2 CH CH 2 NHCH CH 3 OH CH 2 CH CH 2 NHCH OH CH 3 CH 3 OCHCH 2 PROPRANOLOL METOPROLOL.

Slides:



Advertisements
Similar presentations
Catecholamine Agonists and Antagonists. Need-to-know Drugs Norepinephrine Norepinephrine Alpha 1 & 2 and Beta 1 agonist Alpha 1 & 2 and Beta 1 agonist.
Advertisements

Mosby items and derived items © 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. CHAPTER 19 Adrenergic-Blocking Drugs.
Adrenoceptor antagonist drugs Department of pharmacology Zhu ling ( 朱玲 )
Scompenso cardiaco e BPCO: c’è spazio per i beta-bloccanti? Dott. Enrico Strocchi.
Assoc. Prof. Ivan Lambev ANTIADRENERGIC DRUGS (Sympatholytics, Adrenolytics)
B) Drug Therapy (Antihypertensives) ACEi B.B CCB D iuretics. Centrally acting agents: alphametyldopa, HTN + pregnancy.
Pharmacology II The Autonomic Nervous System Adrenergic antagonists
Beta-Adrenergic Blockers  Types of adrenoceptors Alpha-1  Vasoconstriction  Increased peripheral resistance  Increased blood pressure Alpha-2  Inhibition.
ALPHA BLOCKERS Alpha receptors have been further subdivided into alpha1 and alpha2 receptors. Alpha -1 receptors – Upon stimulation, leads to increased.
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 18 Adrenergic Antagonists.
Adrenergic Blockers Asmah Nasser, M.D..
Joseph De Soto MD, PhD, FAIC. Overview The adrenergic antagonist bind adrenoreceptors either reversibly or irreversibly preventing or reducing activation.
Heart Failure. How do  -blockers work? Mechanism for How It Works ・ Beta-blockers "block" the effects of adrenaline on your body's beta-receptors. This.
Adrenoceptor Blockers
ADRENERGIC ANTAGONITS
Compact CNS α 2 Vagus Nerve I-1 Preload Afterload α 1 Renin Baroreflex
Adrenergic Antagonists. These drugs act by either reversibly or irreversibly attaching to the receptor, thus preventing its activation by endogenous catecholamines.
Adrenergic antagonist sympatholytic
Adrenergic Antagonist (Sympatholytics)
Table 1. Biological Responses Mediated by Adrenergic Receptors in the Human Heart Biological ResponseAdrenergic Receptor Mediation Cardiac myocyte growthß.
Classification of Adrenoreceptor Antagonists
Adrenergic & Antiadrenergic Drugs By Dr. F. Tavakoli.
Beta Blockers.
ANTI-ADRENERGIC DRUGS
HuBio 543 September 27, 2007 Neil M. Nathanson K-536A, HSB
Adrenolytics. Adrenoceptor Blockers Adrenolytics Adrenergic Neuron Blockers Sympatholytics Alpha & beta- adrenergic receptor blockers.
Adrenergic Receptor Antagonists Excessive sympathetic activity is characteristic of a number of pathological states including: Hypertension Angina pectoris.
Synthesis & Release of Neurotransmitters
AUTONOMICS MA. JANETTH B. SERRANO, M.D. DPBA. Site and Mode of Action: Site and Mode of Action: 1. Direct Acting –Epinephrine- Dobutamine –Phenylephrine-
Alpha & beta- adrenergic receptor blockers Adrenoceptor Blockers Adrenolytics Adrenergic Neuron Blockers Sympatholytics  Form False Transmitters  Deplete.
Sympatholytics Review 16 December :49 AM.
Adrenoceptor antagonist drugs Pawitra Pulbutr M.Sc. In Pharm (Pharmacology) Pawitra Pulbutr M.Sc. In Pharm (Pharmacology)
Adrenergic Antagonists (Sympatholytics)
بسم الله الرحمن الرحيم.
AUTONOMIC NS DRUGS (2) Dr: Samah Gaafar Al-shaygi.
PHARMACOLOGY OF ANS part 3 General Pharmacology M212
Classification of Adrenoreceptor Antagonists
Autonomics Review 2 March :57 PM.
Sympathetic Nervous System.
Adrenergic Antagonists
 - Adrenoceptors blockers Prof. Hanan Hagar Pharmacology Unit College of Medicine.
SYMPATHOLYTIC AGENTS Beta Receptor Blockers. BETA-ADRENERGIC RECEPTOR BLOCKERS  Widely used clinically for a variety of conditions ; mainly CVS  Dichloro-isoproterenol.
PHARMACOLOGY OFADRENERGICS
Adrenergic Receptor Antagonists These are drugs which antagonize α or β or both α and β adrenergic receptors Adrenergic neurone blocking agents (Sympatholytic)
-ADRENOCEPTOR ANTAGONISTS
Adrenergic Antagonists (Sympatholytics). Basic stages in synaptic transmission.
1 ADRENERGIC ANTAGONITS. 2 ADRENERGIC BLOCKERS ALPHA BLOCKERS Alpha 1 Blockers Nonselective Alpha Blockers Doxazosin Phenoxybenzamine Prazosin Phentolamine.
Sympatholytic & adrenergic blockers -receptor Antagonists
Adrenergic Antagonists
Alpha & beta- adrenergic receptor blockers Adrenoceptor Blockers Adrenolytics Adrenergic Neuron Blockers Sympatholytics  Form False Transmitters  Deplete.
Investigation of the effects of ß-blockers on CVS
PHARMACOLOGY OFADRENERGICS
Sympatholytic & adrenergic blockers -receptor Antagonists
β-adrenergic antagonists
- Adrenoceptors blockers
Adrenoceptor Antagonist Drugs
Alpha adrenergic blockers
β – ADRENERGIC BLOCKERS
ANTI HYPERTENSIVE DRUGS
ANTI HYPERTENSIVE DRUGS
Beta-adrenergic blocking agents
Effect of β-adrenergic Blockers on the Arterial Blood Pressure
Beta blockers and anesthesia
Adrenergic agonists and antagonists
- Adrenoceptors blockers
Sympatholytic & adrenergic blockers -receptor Antagonists
Adrenergic Antagonists
Chaper 20 Adrenoceptor Antagonists
BETABLOCKERS THIRUMURUGAN E MSC CVT. SYMPATHETIC NERVOUS SYSTEM  FIGHT  FEAR  FLIGHT.
Presentation transcript:

BETA ADRENOCEPTOR BLOCKERS

OCH 2 CH CH 2 NHCH CH 3 OH CH 2 CH CH 2 NHCH OH CH 3 CH 3 OCHCH 2 PROPRANOLOL METOPROLOL

CLASSIFICATION OF BETA BLOCKERS  NON - SELECTIVE (  1,  2) BLOCKERS  PURE BLOCKERS  SOTALOL  TIMOLOL  NADOLOL  WITH MEMBRANE STABILIZING ACTIVITY (MSA)  PROPRANOLOL  WITH INTRINSIC SYMPATHETIC ACTIVITY (ISA)  PINDOLOL (MSA  )  CARTEOLOL  PENPUTALOL  WITH ISA & MSA  OXPRENOLOL

 CARDIOSELECTIVE (  1) BLOCKRES  PURE BLOCKERS  ATENOLOL  BISOPROLOL  ESMOLOL  WITH MSA  METOPROLOL  TOLAMOLOL  WITH ISA  PRACTOLOL (Clinically not used now)  CELIPROLOL  WITH ISA & MSA  ACEBUTOLOL  DRUG THAT BLOCK BOTH  &  RECEPTORS  LABETALOL  CARVEDILOL  BUCINDOLOL

BETA ADRENOCEPTOR BLOCKERS PHARMACOKINETIC PROPERTIES LIPID/WATER SOLUBILITY LIPID SOLUBLE PROPRANOLOL TIMOLOL METOPROLOL PENBUTOLOL WATER SOLUBLE NADOLOL ATENOLOL ACEBUTOLOL

DURATION OF ACTION ULTRA SHORT ACTING Half Life ESMOLOL9 Minutes INTERMEDIATE ACTING PROPRANOLOL3 - 5 HOURS TIMOLOL3 - 5 HOURS PINDOLOL HOURS METOPROLOL3 - 4 HOURS LONG ACTING NADOLOL HOURS ATENOLOL5 - 8 HOURS BISOPROLOL HOURS

Pharmacological effects CVS Respiratory system Kidney Metabolic effects CNS Peripheral nervous system Eye Ankle jerk

THERAPEUTIC USES OF BETA ADRENOCEPTOR BLOCKERS  CARDIOVASCULAR DISEASES  Hypertension (Cardio-protective)  Angina pectoris (Prophylaxis)  Myocardial infarction  Primary prevention  Limit the size of infarct  Secondary prevention  Cardiac arrhythmias  Congestive Cardiac Failure Beta1 selective e.g. Metoprolol & Bisoprolol Non selective e.g. carvedolol (Contd)

 Obstructive Cardiomyopathies  Hypertrophic sub aortic stenosis  Fallot’s tetrology  Dissecting aneurysm of aorta  Portal hypertension  Sub arachnoid hemorrhage

 CONDITIONS ASSOCIATED WITH SYMPATHETIC OVER- ACTIVITY  Thyrotoxicosis  Acute anxiety states (Panic syndromes)  Childhood phobias  Acute porphyria  Drug withdrawal syndrome  Pheochromocytoma (alongwith alpha blockers)  Miscellaneous  Glaucoma (Simple open angle) Levobunolol, Betaxolol, Timolol  Migraine (Prophylaxis)  Familial Tremors

ADVERSE EFFECTS CVS CVS Cardio depression, Bradycardia, Heart Blocks, Cardiac Failure Cold extremities, Worsening of Peripheral Vascular Disease RESPIRATION RESPIRATIONBronchospasm CNS CNS Sleep disturbances, Nightmares METABOLIC METABOLIC Masking of Hypoglycemia Increased TGs, Reduced HDL Male Sexual Dysfunction Male Sexual Dysfunction Rashes, Diarrhoea, Muscle cramps Rashes, Diarrhoea, Muscle cramps Oculomucocutaneous syndrome- practolol Oculomucocutaneous syndrome- practolol

DRUGS INTERACTIONS Enzyme inhibitors – Cimetidine Chlorpromazine, hydrallazine, furesimide Enzyme inducers Sympathomimetics Prazosin Clonidine Lignocaine Calcium channel blockers NSAIDs e.g. Indomethacin Antihypertensives

TREATMENT OF OVERDOSAGE Atropine Beta adrenoceptor agonists e.g. isoprenaline, dobutamine, dopamine Glucagon CONTRAINDICATIONS